Continuous ketone monitoring for DKA is now emerging as a promising concept Read More Counseling Patients on Emerging GLP-1 Benefits: How to Balance Evidence and Expectations Apr 27, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 3,023 views Patients today are more informed than ever, but are they always getting the full picture
The basics For those who have read my blogs over the years, youll know that I am a huge fan of anything that supports energy production by improving the function of our cellular furnaces called mitochondria
No, The FDA has warned about unapproved GLP-1 products (including semaglutide and tirzepatide) sold online and mislabeled for research purposes or not for human consumption, with unknown quality and potential harm
Pretty hit or miss
You may qualify with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition such as high blood pressure, diabetes, or high cholesterol